Medikamentenvergleiche
Semaglutide vs. Troglitazone
Semaglutide (Ozempic/Wegovy) vs withdrawn Troglitazone for diabetes. Modern GLP-1 agonist vs TZD pulled in 2000 for fatal hepatotoxicity. Current options compared.
Für diese Seite sind keine Vergleichsdimensionen verfügbar.
Klinischer Kontext
Historical review of withdrawn diabetes drugs or patients asking about discontinued TZDs versus current GLP-1 therapies.
Fazit
Semaglutide is the appropriate modern choice; Troglitazone cannot be used because it was withdrawn for severe liver toxicity.
Alle Medikamentenvergleiche